Success Metrics

Clinical Success Rate
100.0%

Based on 18 completed trials

Completion Rate
100%(18/18)
Active Trials
0(0%)
Results Posted
17%(3 trials)

Phase Distribution

Ph phase_3
2
10%
Ph phase_4
3
15%
Ph phase_1
1
5%
Ph not_applicable
9
45%
Ph phase_2
5
25%

Phase Distribution

1

Early Stage

5

Mid Stage

5

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
1(5.0%)
Phase 2Efficacy & side effects
5(25.0%)
Phase 3Large-scale testing
2(10.0%)
Phase 4Post-market surveillance
3(15.0%)
N/ANon-phased studies
9(45.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

94.7%

18 of 19 finished

Non-Completion Rate

5.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

20

all time

Status Distribution
Completed(18)
Terminated(1)
Other(1)

Detailed Status

Completed18
Withdrawn1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (5.0%)
Phase 25 (25.0%)
Phase 32 (10.0%)
Phase 43 (15.0%)
N/A9 (45.0%)

Trials by Status

completed1890%
withdrawn15%
unknown15%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT06047145Not Applicable

Evaluation of Soy Isoflavones on Skin Ageing Parameters

Completed
NCT04880369Not Applicable

Phytoestrogens and Breast Cancer - Effects of Phytoestrogens on Markers of Disease Progression and Gene Expression

Withdrawn
NCT01219075Not Applicable

Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer

Completed
NCT00665860Not Applicable

Safety and Effectiveness of Soy Phytoestrogens to Prevent Bone Loss

Completed
NCT01958372Phase 1

Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer

Completed
NCT00345813Phase 2

Soy Supplements in Treating Patients Undergoing Surgery for Localized Prostate Cancer

Completed
NCT00343434Not Applicable

Soy-Based Meal Replacement in Helping Women With Stage I, Stage II, or Stage III Breast Cancer in Complete Remission Lose Weight

Completed
NCT00076050Phase 3

Using Soy Estrogens to Prevent Bone Loss and Other Menopausal Symptoms

Completed
NCT02007200Phase 2

Soy Isoflavones in Preventing Head and Neck Cancer Recurrence in Patients With Stage I-IV Head and Neck Cancer Undergoing Surgery

Completed
NCT02195609Phase 4

Evaluate the Effect of Omega-3 vs Soy Isoflavones in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Completed
NCT02026518Phase 4

Effect of Cholecalciferol, Soy Isoflavones in Patients With Irritable Bowel Syndrome

Completed
NCT00078923Phase 2

Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate

Completed
NCT00003100Not Applicable

Dietary Soy Isoflavones for the Prevention of Cancer

Unknown
NCT00513916Phase 3

Effect of Dietary Soy on Estrogens in Breast Fluid, Blood, and Urine Samples From Healthy Women

Completed
NCT00029796Phase 2

Isoflavones and Acute-phase Response in Chronic Renal Failure

Completed
NCT00043745Phase 2

Bone Response to Soy Isoflavones in Women

Completed
NCT00042731Not Applicable

Isoflavones & Lycopene in Localized Prostate Ca:Prior to Radical Prostatectomy

Completed
NCT01401946Phase 4

Soy Isoflavone Tablets: Effects on Sleep, Quality of Life, Symptoms and Cognitive Function in Menopausal Women

Completed
NCT00277446Not Applicable

Dietary Supplementation With Soy Isoflavones in Asthma

Completed
NCT00203255Not Applicable

Clinical Study Examining Use of an Over-the-Counter Supplement for the Prevention of Menstrually-Associated Migraine Headache

Completed

All 20 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
20